Knowledge products overview

10th March 2026

Electronic Medicines Compendium (emc)

For March, 50 new medicines have been added, and numerous medicines have been amended.

10th March 2026

Drug Monitoring Checker

This update contains 1 new monograph.

New monographs: Semaglutide.

10th March 2026

Martindale: The Complete Drug Reference

This update contains 7 new monographs and 13 existing monographs have been updated. Preparations have also been updated for 5 countries.

New Monographs

• BAM-15 is an AMP-activated protein kinase (AMPK) activator. It may be subject to abuse in sport.
• Elranatamab is a bispecific humanised monoclonal antibody that binds to both the B-cell maturation antigen (BCMA) and CD3 receptor on T-cells. It is used in the treatment of relapsed or refractory multiple myeloma.
• Fezolinetant is a non-hormonal neurokinin-3 receptor antagonist used in the treatment of vasomotor symptoms associated with the menopause.
• Fluorafinil is a potent analogue of adrafinil and may be subject to abuse in sport.
• Lauflumide is a potent analogue of modafinil and may be subject to abuse in sport.
• Ritlecitinib inhibits Janus kinase 3 (JAK3) and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) kinase family. It is used in the treatment of alopecia areata.
• α-Naphthoflavone is reported to be an aromatase inhibitor. It may be subject to abuse in sport.

Selective Updates – some new, re-validated or changed information

Monographs

• Belinostat
• Botulinum Toxin Type A (formerly Botulinum A Toxin)
• Botulinum Toxin Type B (formerly Botulinum B Toxin)
• Chloral Hydrate (formerly Cloral Hydrate)
• Colchicine
• d-Alpha Tocopheryl Acetate (formerly d-Alpha Tocoferil Acetate)
• d-Alpha Tocopheryl Hydrogen Succinate (formerly d-Alpha Tocoferil Acid Succinate)
• dl-Alpha Tocopheryl Acetate (formerly dl-Alpha Tocoferil Acetate)
• dl-Alpha Tocopheryl Hydrogen Succinate (formerly dl-Alpha Tocoferil Acid Succinate)
• Obeticholic Acid
• Pregabalin
• Topiramate
• Valproate

Updated names, synonyms and codes; official standards; official preparations

• ATC codes 2026
• ATC vet codes 2026
• BAN 2017 Suppl. 3
• Ph. Eur. 11.5
• Ph. Eur. 11.6
• WADA 2026 processing

Proprietary Preparations and Manufacturers updated for the following countries and regions:

• Austria
• Canada
• UAE
• UK^†
• USA^†

† Countries updated on an ongoing basis

10th March 2026

BNF for Children

This update contains 2 significant changes.

Significant Changes:

• Antibacterials, use for prophylaxis: updated guidance for endoscopic retrograde cholangiopancreatography.
• Supply of medicines: updated guidance on labelling of prescribed medicines.

10th March 2026

AHFS Drug Information

This update contains 7 new monographs, 37 revised monographs and 40
discontinued monographs.

New monographs: Aficamten; Depemokimab-ulaa; Etripamil;
Etuvetidigene Autotemcel; Ferric Maltol; Lerodalcibep-liga; Zoliflodacin

Revised monographs: AbobotulinumtoxinA; Antihemophilic Factor
(recombinant), PEGylated-aucl; Beremagene Geperpavec-svdt;
Clesrovimab-cfor; Coagulation Factor Xa (recombinant), Inactivated-zhzo;
Colchicine; Cosibelimab-ipdl; COVID-19 Vaccine, Adjuvanted (Novavax)
(2025-2026 Formula); COVID-19 Vaccine, mRNA (Moderna) (2025-2026);
COVID-19 Vaccine, mRNA (Pfizer-BioNTech) (2025-2026 Formula);
DaxibotulinumtoxinA-lanm; Denosumab; Dordaviprone Hydrochloride;
Hepatitis A Vaccine Inactivated; Human Papillomavirus Vaccine
Recombinant; Indapamide; Influenza Vaccine Inactivated; Influenza
Vaccine Live Intranasal; Influenza Vaccine Recombinant; Insulin Human;
Liothyronine Sodium; Measles, Mumps, and Rubella Virus Vaccine Live;
Meningococcal Group B Vaccine; Meningococcal Groups A, C, Y, and W-135
Vaccine; Minocycline Hydrochloride (Topical); Nintedanib Esylate;
Nirsevimab-alip; Omidubicel-onlv; Pirfenidone; Pneumococcal Vaccine;
Poliovirus Vaccine Inactivated; raNITIdine Hydrochloride; Remibrutinib;
Sebetralstat; Sodium Thiosulfate (Protectant); Valsartan; Varicella Virus
Vaccine Live.

Discontinued Monographs: Adefovir Dipivoxil; Amifostine; Amino Acid
Injections; Amobarbital Sodium; Amphetamines General Statement;
Bezlotoxumab; Cefepime Hydrochloride and Enmetazobactam;
Chikungunya Vaccine Live; Chikungunya Vaccine, Recombinant; Codeine
(Antitussive); Dolasetron Mesylate; Electrolyte Solutions; Enfuvirtide;
Ergoloid Mesylates; Ethotoin; Fat Emulsions; Fenoldopam Mesylate;
Gemifloxacin Mesylate; Gentian Violet; Gepirone Hydrochloride; Green
Soap; Histoplasmin; Irrigating Solutions; Levamlodipine Maleate;
Lodoxamide Tromethamine; Measles Virus Vaccine Live; Multivitamins;
Mumps Virus Vaccine Live; Obeticholic Acid; Oliceridine Fumarate;
Oxandrolone; Ozenoxacin; Palivizumab; Pancuronium Bromide;
Pentazocine; Peritoneal Dialysis Solutions; Retapamulin; Rubella Virus
Vaccine Live; Thyroid; Thyroid Agents General Statement.

10th March 2026

British National Formulary

This update contains 3 significant changes, 1 new monograph, 2 new preparations, and 1 deleted monograph.

Significant Changes:

• Antibacterials, use for prophylaxis: updated guidance for endoscopic retrograde cholangiopancreatography, transrectal prostate biopsy, and transurethral resection of prostate.
• Migraine: updated guidance on management.
• Obeticholic acid: new guidance for use in hepatic impairment.

New Monographs:

• Blenrep® [belantamab mafodotin].

New Preparations: Ocrevus® [ocrelizumab]; Vevizye® [ciclosporin].

Deleted Monographs: Felbinac.